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Oncostatin M (OSM) is a member of IL-6 family cytokines with pleiotropic functions. 
A previous study showed that OSM contributed to liver regeneration after acute liver 
injury, partly by regulating the remodeling of extracellular matrix. However, the role of 
OSM in chronically injured liver accompanying fibrosis is unknown. The current 
studies show that OSM is continuously expressed during fibrogenesis and responsible 
for the promotion of fibrosis. OSM-deficient mouse exhibited significant reduction of 
fibrosis in chronically injured liver compared to wild-type mouse. Conversely, 
continuous expression of OSM in normal liver by hydrodynamic tail vein injection of 
OSM cDNA was sufficient to induce remarkable fibrosis with the up-regulation of 
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several fibrogenic genes. Importantly, no sign of hepatic injury was observed in this 
case, suggesting that OSM-induced fibrosis was not caused by inflammation or hepatic 
damage but the fibrogenic property of OSM. The OSM receptor was predominantly 
expressed on hepatic stellate cells (HSCs) and liver macrophages (LMs). OSM directly 
up-regulated the expression of tissue inhibitor of metalloproteinase-1 gene in HSC in 
vitro, whereas it promoted that of collagen gene via the activation of LMs. In 
chronically injured liver, infiltrating bone marrow-derived macrophages were more 
responsive to OSM for the induction of fibrosis-related genes than liver resident 
macrophages. In conclusion, OSM is a powerful fibrogenic factor and its persistent 
expression in chronic liver diseases can be a risk factor for liver fibrosis. OSM is a 
possible therapeutic target for liver fibrosis. 
 
